The Vice President of Quality will define and drive the quality vision and strategy at Remix Therapeutics, overseeing quality management systems, compliance, and inspections while building a quality organization as the company advances its oncology drug pipeline.

The Vice President of Biostatistics leads the statistical strategy for drug development in oncology, oversees clinical trial design, and manages external partnerships while ensuring regulatory compliance.

The Associate Director will support corporate partnerships and fundraising for Remix Therapeutics, conducting analyses and preparing communications for stakeholders.